Proteomics of apheresis platelet supernatants during routine storage: Gender-related differences

Journal of Proteomics

Volumn 112, Issue , 2014, Pages 190-209

  Dzieciatkowska, Monika ^a   D'Alessandro, Angelo ^a   Burke, Timothy A ^b   Kelher, Marguerite R ^b   Moore, Ernest E ^a   Banerjee, Anirban ^a   Silliman, Christopher C ^a,b   West, Bernadette F ^b   Hansen, Kirk C ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Bonfils Blood Center   (United States)

Author keywords

Donor; Human; Label free quantitation; Mass spectrometry; Proteomics; Transfusion medicine

Indexed keywords

COMPLEMENT; PLASMA PROTEIN; PROTEOME; STABLE ISOTOPE; STRUCTURAL PROTEIN; THROMBOCYTE CONCENTRATE;

APHERESIS; ARTICLE; BLOOD CLOTTING; CELL ADHESION; FEMALE; HUMAN; INFLAMMATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEOMICS; SEX DIFFERENCE; SUPERNATANT; THROMBOCYTE PRESERVATION; BLOOD STORAGE; CLINICAL TRIAL; CYTOLOGY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; SEXUAL DEVELOPMENT; THROMBOCYTE; THROMBOCYTOPHERESIS;

BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELETPHERESIS; PROTEOMICS; SEX CHARACTERISTICS;

EID: 84907729573     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.08.016     Document Type: Article

References (42)

1. Devine D.V., Serrano K. The platelet storage lesion. Clin Lab Med 2010, 30:475-487.
2. Ohto H., Nollet K.E. Overview on platelet preservation: better controls over storage lesion. Transfus Apher Sci 2011, 44:321-325.
3. Shrivastava M. The platelet storage lesion. Transfus Apher Sci 2009, 41:105-113.
4. Goodrich RP, Li J, Pieters H, Crookes R, Roodt J, Heyns Adu P. Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sang 2006, 90:279-285.
5. Liumbruno G., D'Alessandro A., Grazzini G., Zolla L. Blood-related proteomics. J Proteomics 2010, 73(3):483-507.
6. Schubert P., Devine D.V. De novo protein synthesis in mature platelets: a consideration for transfusion medicine. Vox Sang 2010, 99:112-122.
7. Burkhart J.M., Gambaryan S., Watson S.P., Jurk K., Walter U., Sickmann A., et al. What can proteomics tell us about platelets?. Circ Res 2014, 114(7):1204-1219.
8. Senis Y., Garcia A. Platelet proteomics: state of the art and future perspective. Methods Mol Biol 2012, 788:367-399.
9. Prudent M., D'Alessandro A., Cazenave J.P., Devine D.V., Gachet C., Greinacher A., et al. Proteome changes in platelets after pathogen inactivation-an interlaboratory consensus. Transfus Med Rev 2014, 28(2):72-83.
10. Zufferey A., Fontana P., Reny J.L., Nolli S., Sanchez J.C. Platelet proteomics. Mass Spectrom Rev 2012, 31:331-351.
11. Coppinger J.A., Cagney G., Toomey S., Kislinger T., Belton O., McRedmond J.P., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in atherosclerotic lesions. Blood 2004, 103:2096-2104.
12. Thon J.N., Schubert P., Duguay M., Serrano K., Lin S., Kast J., et al. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 2008, 48:425-435.
13. Thiele T., Steil L., Gebhard S., Scharf C., Hammer E., Brigulla M., et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007, 47:1221-1233.
14. Thiele T., Iuga C., Janetzky S., Schwertz H., Gesell Salazar M., Furll B., et al. Early storage lesions in apheresis platelets are induced by the activation of the integrin alphaIIbbeta(3) and focal adhesion signaling pathways. J Proteomics 2012, 76:297-315.
15. Prudent M., Crettaz D., Delobel J., Tissot J.D., Lion N. Proteomic analysis of Intercept-treated platelets. J Proteomics 2012, 76:316-328.
16. Marrocco C, D'Alessandro A, Girelli G, Zolla L. Proteomic analysis of platelets treated with gamma irradiation versus a commercial photochemical pathogen reduction technology. Transfusion 2013, 53:1808-1820.
17. Schubert P., Culibrk B., Coupland D., Scammell K., Gyongyossy-Issa M., Devine D.V. Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage. Transfusion 2012, 52:397-408.
18. Prudent M., Sonego G., Abonnenc M., Tissot J.D., Lion N. LC-MS/MS analysis and comparison of oxidative damages on peptides induced by pathogen reduction technologies for platelets. J Am Soc Mass Spectrom 2014, 25(4):651-661.
19. Harr J.N., Moore E.E., Chin T.L., Gonzalez E., Wohlauer M., Banerjee A., et al. Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg 2013, 74(3):756-762.
20. Wurtz V., Hechler B., Ohlmann P., Isola H., Schaeffer-Reiss C., Cazenave J.P., et al. Identification of platelet factor 4 and β-thromboglobulin by profiling and liquid chromatography tandem mass spectrometry of supernatant peptides in stored apheresis and buffy-coat platelet concentrates. Transfusion 2007, 47:1099-1100.
21. Silliman C.C., Bjornsen A.J., Wyman T.H., Kehler M., Allard J., Bieber S., et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003, 43(5):633-640.
22. Kanter J., Khan S.Y., Kelher M., Gore L., Silliman C.C. Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates. Clin Cancer Res 2008, 14(12):3942-3947.
23. Dineen S.P., Roland C.L., Toombs J.E., Kehler M., Silliman C.C., Brekken R.A., et al. The acellular fraction of stored platelets promotes tumor cell invasion. J Surg Res 2009, 153(1):132-137.
24. Coppinger J.A., Cagney G., Toomey S., Kislinger T., Belton O., McRedmond J.P., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103(6):2096-2104.
25. Silliman C.C., Dzieciatkowska M., Moore E.E., Kehler M., Banerjee A., Liang X., et al. Proteomic analyses of human plasma: Venus versus Mars. Transfusion 2012, 52(2):417-424.
26. Pratt J.M., Simpson D.M., Doherty M.K., Rivers J., Gaskell S.J., Beynon R.J. Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes. Nat Protoc 2006, 1(2):1029-1043.
27. Dzieciatkowska M., Hill R., Hansen K.C. GeLC-MS/MS analysis of complex protein mixtures. Methods Mol Biol 2014, 1156:53-66.
28. MacLean B., Tomazela D.M., Shulman N., Chambers M., Finney G.L., Frewen B., et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010, 26(7):966-968.
29. Glenister K.M., Payne K.A., Sparrow R.L. Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage. Transfusion 2008, 48:99-107.
30. Egidi M.G., Rinalducci S., Marrocco C., Vaglio S., Zolla L. Proteomic analysis of plasma derived from platelet buffy coats during storage at room temperature. An application of ProteoMiner (TM) technology. Platelets 2011, 22:252-269.
31. Skornicka E.L., Kiyatkina N., Weber M.C., Tykocinski M.L., Koo P.H. Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production. Cell Immunol 2004, 232(1-2):144-156.
32. Breet N.J., Sluman M.A., van Berkel M.A., van Wekum J.W., Bouman H.J., Harmsze A.M., et al. Effect of gender difference on platelet reactivity. Neth Heart J 2011, 19(11):451-457.
33. Biino G., Santimone I., Minelli C., Sorice R., Frongia B., Traglia M., et al. Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects' data. PLoS One 2013, 8(1):e54289.
34. Petersen C.M., Jensen P.H., Bukh A., Sunde L., Lamm L.U., Ingerslev J. Pregnancy zone protein: a re-evaluation of serum levels in healthy women and in women suffering from breast cancer or trophoblastic disease. Scand J Clin Lab Invest 1990, 50(5):479-485.
35. Gnatenko D.V., Dunn J.J., McCorkle S.R., Weissmann D., Perrotta P.L., Bahou W.F. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003, 101:2285-2293.
36. Silberstein F.C., De Simone R., Levi G., Aloisi F. Cytokine-regulated expression of platelet-derived growth factor gene and protein in cultured human astrocytes. J Neurochem 1996, 66(4):1409-1417.
37. Dzieciatkowska M., Wohlauer M.V., Moore E.E., Damle S., Peltz E., Campsen J., et al. Proteomic analysis of human mesenteric lymph. Shock 2011, 35(4):331-338.
38. Lundequist A., Abrink M., Pejler G. Mast cell-dependent activation of pro matrix metalloprotease 2: A role for serglycin proteoglycan-dependent mast cell proteases. Biol Chem 2006, 387(10-11):1513-1519.
39. Jeffery C.J. Moonlighting proteins: old proteins learning new tricks. Trends Genet 2003, 19(8):415-417.
40. Polati R., Castagna A., Bossi A.M., Alberio T., De Domenico I., Kaplan J., et al. Murine macrophages response to iron. J Proteomics 2012, 76:10-27.
41. Chen J.W., Dodia C., Feinstein S.I., Jain M.K., Fisher A.B. 1-Cys peroxiredoxin, a bifunctional enzyme with glutathion eperoxidase and phospholipase A2 activities. J Biol Chem 2000, 275:28421-28427.
42. Gajic O., Yilmaz M., Iscimen R., Kor D.J., Winters J.L., Moore S.B., et al. Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components. Crit Care Med 2007, 35(7):1645-1648.